Gene · 5205
Papers1,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Osteo-oto-hepato-enteric syndrome caused by UNC45A deficiency. | Front Genet | 2022 | 36699472 | PubTator, text mining | PubMed |
| Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)-In Vitro Testing. | Pharmaceutics | 2022 | 36678658 | PubTator, text mining | PubMed |
| Development and validation of a prognostic model and gene co-expression networks for breast carcinoma based on scRNA-seq and bulk-seq data. | Ann Transl Med | 2022 | 36660733 | PubTator, text mining | PubMed |
| Progressive Familial Intrahepatic Cholestasis Type 3 Homozygous Pathogenic Variant c.2906G>A in the ATP Binding Cassette Subfamily B Member 4 (ABCB4) Gene: A Case Report of an Unusual Presentation. | Cureus | 2022 | 36644077 | PubTator, text mining | PubMed |
| Global transcriptional responses of pneumococcus to human blood components and cerebrospinal fluid. | Front Microbiol | 2022 | 36620004 | PubTator, text mining | PubMed |
| Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in ABCB4 in China. | Front Med (Lausanne) | 2022 | 36569137 | PubTator, text mining | PubMed |
| Breast tumor IGF1R regulates cell adhesion and metastasis: alignment of mouse single cell and human breast cancer transcriptomics. | Front Oncol | 2022 | 36568144 | PubTator, text mining | PubMed |
| Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. | J Transl Med | 2022 | 36564797 | PubTator, text mining | PubMed |
| Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. | J Pers Med | 2022 | 36556227 | PubTator, text mining | PubMed |
| Internal Ileal Diversion as Treatment for Progressive Familial Intrahepatic Cholestasis Type 1-Associated Graft Inflammation and Steatosis after Liver Transplantation. | Children (Basel) | 2022 | 36553407 | PubTator, text mining | PubMed |
| SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets. | Cancers (Basel) | 2022 | 36551516 | PubTator, text mining | PubMed |
| Clinical and genetic characterization of pediatric patients with progressive familial intrahepatic cholestasis type 3 (PFIC3): identification of 14 novel ABCB4 variants and review of the literatures. | Orphanet J Rare Dis | 2022 | 36550572 | PubTator, text mining | PubMed |
| Hereditary spherocytosis complicated by intrahepatic cholestasis: two case reports. | Ann Transl Med | 2022 | 36544651 | PubTator, text mining | PubMed |
| Over-expression of miR-183-5p or miR-492 triggers invasion and proliferation and loss of polarity in non-neoplastic breast epithelium. | Sci Rep | 2022 | 36539576 | PubTator, text mining | PubMed |
| Prognosis stratification in breast cancer and characterization of immunosuppressive microenvironment through a pyrimidine metabolism-related signature. | Front Immunol | 2022 | 36524129 | PubTator, text mining | PubMed |
| Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors. | Front Immunol | 2022 | 36505421 | PubTator, text mining | PubMed |
| Ethnic and racial-specific differences in levels of centrosome-associated mitotic kinases, proliferative and epithelial-to-mesenchymal markers in breast cancers. | Cell Div | 2022 | 36494865 | PubTator, text mining | PubMed |
| Synthesis and Iodine Adsorption Properties of Organometallic Copolymers with Propeller-Shaped Fe(II) Clathrochelates Bridged by Different Diaryl Thioether and Their Oxidized Sulfone Derivatives. | Polymers (Basel) | 2022 | 36432945 | PubTator, text mining | PubMed |
| Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer. | Cancers (Basel) | 2022 | 36428736 | PubTator, text mining | PubMed |
| Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Reveals a Tissue-Resident Macrophage-Related Signature for Predicting Immunotherapy Response in Breast Cancer Patients. | Cancers (Basel) | 2022 | 36428599 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5205/papers?page=16